title: [Complications of Descemet's membrane endothelial keratoplasty].
abstract: Descemet's membrane endothelial keratoplasty (DMEK) is a relatively new, but now established surgical procedure to cure corneal endothelial disorders. However, there are donor- and recipient-associated sources of potential complications, some of which can be identified and addressed prior to the procedure and others that may lead to intra- or postoperative problems. Preoperatively, risk factors for a limited visual outcome (ocular comorbidities, previous ocular surgery, subepithelial/stromal scars) and the specific indication for DMEK should be discussed with the patient. Intraoperatively, young donor age can be associated with a particularly elastic graft, which may be difficult to unfold. Such transplants are not appropriate for particularly difficult recipient situations (very opaque cornea, history of vitreoretinal surgery). Postoperatively, transplant dehiscence is the most common complication, which in many cases can be managed by reinjection of air (or a 20 % SF6 gas/air mix) into the anterior chamber. An elevation of the intraocular pressure after DMEK is often caused by a reaction to topical steroid therapy. Although immune rejections after DMEK are less likely than after Descemet's stripping automated endothelial keratoplasty (DSAEK) and perforating keratoplasty, adequate treatment with topical steroidal drugs is recommended. These common and several rare complications are discussed in this review.
authors.affiliation: Universitätsaugenklinik Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland. kristina.spaniol@med.uni-duesseldorf.de.
authors.forename: K
authors.initials: K
authors.lastname: Spaniol
authors.affiliation: Universitätsaugenklinik Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Borrelli
authors.affiliation: Universitätsaugenklinik Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Holtmann
authors.affiliation: Universitätsaugenklinik Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.
authors.forename: S
authors.initials: S
authors.lastname: Schrader
authors.affiliation: Universitätsaugenklinik Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.
authors.forename: G
authors.initials: G
authors.lastname: Geerling
mesh_terms: D003316:Corneal Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D057111:Descemet Stripping Endothelial Keratoplasty / Q000009:adverse effects*; D019317:Evidence-Based Medicine; D005131:Eye Injuries / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006084:Graft Rejection / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D009798:Ocular Hypertension / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D016896:Treatment Outcome; D014786:Vision Disorders / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control
keywords: Antigen–antibody reactions; Descemet’s membrane endothelial keratoplasty; Glaucoma; Tissue donors; Transplant recipients